HC Wainwright Lowers Neumora Therapeutics (NASDAQ:NMRA) Price Target to $18.00
Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) had its target price lowered by equities researchers at HC Wainwright from $30.00 to $18.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. A number of other research analysts have also commented on the company. Needham & Company […]
Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) had its target price lowered by equities researchers at HC Wainwright from $30.00 to $18.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. A number of other research analysts have also commented on the company. Needham & Company […]
